Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Brain-penetrant chromone oxime derivative for the therapy of levodopa-induced dyskinesia

Brain-penetrant chromone oxime derivative for the therapy of levodopa-induced dyskinesia

US Patent 10532057 · Granted Jan 14, 2020

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Chromone oxime derivative and its use as allosteric modulator of metabotropic gl2019
Chromone oxime derivative and its use as allosteric modulator of metabotropic gl2019
Chromone oxime derivative and its use as allosteric modulator of metabotropic gl2018
Chromone oxime derivative and its use as allosteric modulator of metabotropic gl2018